Press-release for stocks published on this year related to pharmaceuticals

Prices are updated after-hours

published : This year tags : Pharmaceuticals

save search

ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice
Published: 2024-04-19 (Crawled : 21:00) - globenewswire.com
ASLN | News | $0.54 0.0% 26K

Health Technology

| Email alert Add to watchlist
nasdaq pharmaceuticals

Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
Published: 2024-04-19 (Crawled : 20:00) - globenewswire.com
HEPA | News | $2.11 -0.09% -0.09% 73K

Health Technology

| Email alert Add to watchlist
pharmaceuticals trial

ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET
Published: 2024-04-18 (Crawled : 20:00) - globenewswire.com
ANIP S | $65.49 1.41% 1.39% 210K

Health Technology

| -0.41% | O: -2.36% H: 2.46% C: 1.99%
first pharmaceuticals financial results

Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated Pre-Clinical Studies at European Society of Clinical Microbiology & Infectious Diseases Global (ESCMID Global) 2024
Published: 2024-04-18 (Crawled : 13:00) - biospace.com/
ZLAB | $14.08 -0.99% -0.99% 470K

Health Technology

| 2.55% | O: -1.24% H: 0.0% C: 0.0%
nuzyra pre-clinical pharmaceuticals global

Lexicon Pharmaceuticals to Host 2024 Investor Day
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
LXRX | $1.655 1.53% 1.51% 3M

Health Technology

| -4.9% | O: -4.61% H: 0.0% C: 0.0%
day pharmaceuticals

Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting
Published: 2024-04-17 (Crawled : 23:00) - biospace.com/
ACAD | $16.82 -1.47% -1.49% 3.5M

Health Technology

| -1.52% | O: 0.76% H: 0.0% C: 0.0%
neurology pharmaceuticals meeting

Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
Published: 2024-04-17 (Crawled : 23:00) - biospace.com/
JAZZ | $109.96 0.63% 0.63% 760K

Health Technology

| 0.96% | O: 0.13% H: 0.2% C: -1.78%
first report pharmaceuticals financial results

Lipella Pharmaceuticals Expands its Advisory Board
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
LIPO | $0.707 -0.88% -0.89% 6.4K

| -0.96% | O: -0.96% H: 5.56% C: 4.17%
pharmaceuticals

Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak
Published: 2024-04-17 (Crawled : 13:00) - prnewswire.com
VNDA | $5.11 2.82% 2.74% 2.4M

Health Technology

| 27.75% | O: 35.5% H: 4.61% C: -3.32%
unsolicited pharmaceuticals

Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
Published: 2024-04-17 (Crawled : 13:00) - biospace.com/
ENTA | $13.28 0.38% 0.38% 140K

Health Technology

| -13.28% | O: -4.2% H: 0.0% C: 0.0%
presentation pharmaceuticals global

NeuroBo Pharmaceuticals Doses First Patient in Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity
Published: 2024-04-17 (Crawled : 12:00) - prnewswire.com
NRBO | $3.325 -3.34% -3.46% 21K

Health Technology

| -0.88% | O: 8.53% H: 0.0% C: -6.23%
da-1726 obesity first treatment pharmaceuticals for trial

Milestone® Pharmaceuticals to Present Data on Etripamil at the Preventative Cardiovascular Nursing Symposium
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
MIST | $1.64 0.61% 0.61% 30K

Health Technology

| -4.09% | O: 5.26% H: 1.11% C: -2.78%
milestone etripamil symposium pharmaceuticals cardiovascular

Future Pak Confirms Proposal to Acquire Vanda Pharmaceuticals for $7.25 to $7.75 Per Share in Cash
Published: 2024-04-17 (Crawled : 12:00) - biospace.com/
MC | $51.65 1.33% 0.0% 590K

Finance

| 0.91% | O: 0.56% H: 0.8% C: -0.41%
VNDA | $5.11 2.82% 2.74% 2.4M

Health Technology

| 27.75% | O: 35.5% H: 4.61% C: -3.32%
pharmaceuticals acquire for proposal

Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
LIPO | $0.707 -0.88% -0.89% 6.4K

| -0.96% | O: -0.96% H: 5.56% C: 4.17%
pharmaceuticals

NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
Published: 2024-04-17 (Crawled : 12:00) - biospace.com/
NBY | $0.0824 -1.91% 0.0% 1.6M

Health Technology

| 10.96% | O: 38.7% H: 0.0% C: -20.0%
sales first revenue care pharmaceuticals for

Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024
Published: 2024-04-16 (Crawled : 20:00) - globenewswire.com
REGN | $896.27 0.26% 0.25% 500K

Health Technology

| 0.3% | O: 1.09% H: 0.86% C: -0.3%
KNSA | $16.93 0.3% 0.3% 380K

Health Technology

| -3.15% | O: 0.46% H: 0.17% C: -3.36%
first report pharmaceuticals financial results

Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-16 (Crawled : 20:00) - globenewswire.com
MDGL | $212.33 -4.47% -4.68% 620K

Health Technology

| -8.99% | O: 1.26% H: 0.0% C: -3.21%
nasdaq pharmaceuticals grants

Rhythm Pharmaceuticals Announces New Employment Inducement Grants
Published: 2024-04-16 (Crawled : 20:00) - globenewswire.com
RYTM A | $37.975 -0.35% -0.36% 620K

Health Technology